Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-06 Drake Michael V Director Grant or award +114.03 6,030.19
2026-08-07 Drake Michael V Director Grant or award +63.88 5,876.16
2026-05-19 Drake Michael V Director Grant or award +665 5,774.29
2026-05-05 Drake Michael V Director Grant or award +79.64 5,109.29
2025-11-07 Drake Michael V Director Grant or award +218.61 4,958.64
2025-08-08 Drake Michael V Director Grant or award +121.43 4,699.03
2025-05-23 Drake Michael V Director Grant or award +809 4,546.6
2025-05-06 Drake Michael V Director Grant or award +129.42 3,737.6
2024-11-04 Drake Michael V Director Grant or award +220.88 3,552.18
2024-08-09 Drake Michael V Director Grant or award +108.53 3,307.3
2024-05-31 Drake Michael V Director Grant or award +719 3,174.77
2024-05-07 Drake Michael V Director Grant or award +116.55 2,455.77
2023-11-03 Drake Michael V Director Grant or award +240.87 2,301.22
2023-08-08 Drake Michael V Director Grant or award +124.62 2,024.35
2023-05-19 Drake Michael V Director Grant or award +939 1,899.73
2023-05-02 Drake Michael V Director Grant or award +137.73 960.73
2022-11-08 Drake Michael V Director Grant or award +171 810
2022-08-09 Drake Michael V Director Grant or award +634 634

Page 1 of 1 · 18 trades